188 related articles for article (PubMed ID: 15716381)
21. Context dependent role of the CD36--thrombospondin--histidine-rich glycoprotein axis in tumor angiogenesis and growth.
Hale JS; Li M; Sinyuk M; Jahnen-Dechent W; Lathia JD; Silverstein RL
PLoS One; 2012; 7(7):e40033. PubMed ID: 22808089
[TBL] [Abstract][Full Text] [Related]
22. 15(S)-hydroxyeicosatetraenoic acid induces angiogenesis via activation of PI3K-Akt-mTOR-S6K1 signaling.
Zhang B; Cao H; Rao GN
Cancer Res; 2005 Aug; 65(16):7283-91. PubMed ID: 16103079
[TBL] [Abstract][Full Text] [Related]
23. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways.
Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z
Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629
[TBL] [Abstract][Full Text] [Related]
24. Diallyl trisulfide inhibits angiogenic features of human umbilical vein endothelial cells by causing Akt inactivation and down-regulation of VEGF and VEGF-R2.
Xiao D; Li M; Herman-Antosiewicz A; Antosiewicz J; Xiao H; Lew KL; Zeng Y; Marynowski SW; Singh SV
Nutr Cancer; 2006; 55(1):94-107. PubMed ID: 16965246
[TBL] [Abstract][Full Text] [Related]
25. Receptor protein tyrosine phosphatase beta/zeta is a functional binding partner for vascular endothelial growth factor.
Koutsioumpa M; Poimenidi E; Pantazaka E; Theodoropoulou C; Skoura A; Megalooikonomou V; Kieffer N; Courty J; Mizumoto S; Sugahara K; Papadimitriou E
Mol Cancer; 2015 Feb; 14(1):19. PubMed ID: 25644401
[TBL] [Abstract][Full Text] [Related]
26. Endothelial cell activation of the smooth muscle cell phosphoinositide 3-kinase/Akt pathway promotes differentiation.
Brown DJ; Rzucidlo EM; Merenick BL; Wagner RJ; Martin KA; Powell RJ
J Vasc Surg; 2005 Mar; 41(3):509-16. PubMed ID: 15838487
[TBL] [Abstract][Full Text] [Related]
27. Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1.
Nunes SS; Outeiro-Bernstein MA; Juliano L; Vardiero F; Nader HB; Woods A; Legrand C; Morandi V
J Cell Physiol; 2008 Mar; 214(3):828-37. PubMed ID: 17879962
[TBL] [Abstract][Full Text] [Related]
28. Both mitogen-activated protein kinase and phosphatidylinositol 3-kinase signalling are required in epidermal growth factor-induced human trophoblast migration.
Qiu Q; Yang M; Tsang BK; Gruslin A
Mol Hum Reprod; 2004 Sep; 10(9):677-84. PubMed ID: 15235105
[TBL] [Abstract][Full Text] [Related]
29. IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species--dependent endothelial migration and proliferation.
Yamaoka-Tojo M; Ushio-Fukai M; Hilenski L; Dikalov SI; Chen YE; Tojo T; Fukai T; Fujimoto M; Patrushev NA; Wang N; Kontos CD; Bloom GS; Alexander RW
Circ Res; 2004 Aug; 95(3):276-83. PubMed ID: 15217908
[TBL] [Abstract][Full Text] [Related]
30. CD36: a critical anti-angiogenic receptor.
Simantov R; Silverstein RL
Front Biosci; 2003 Sep; 8():s874-82. PubMed ID: 12957861
[TBL] [Abstract][Full Text] [Related]
31. Butyrate-treated colonic Caco-2 cells exhibit defective integrin-mediated signaling together with increased apoptosis and differentiation.
Lévy P; Robin H; Bertrand F; Kornprobst M; Capeau J
J Cell Physiol; 2003 Dec; 197(3):336-47. PubMed ID: 14566963
[TBL] [Abstract][Full Text] [Related]
32. CD36-TSP-HRGP interactions in the regulation of angiogenesis.
Silverstein RL; Febbraio M
Curr Pharm Des; 2007; 13(35):3559-67. PubMed ID: 18220792
[TBL] [Abstract][Full Text] [Related]
33. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1.
Isenberg JS; Ridnour LA; Dimitry J; Frazier WA; Wink DA; Roberts DD
J Biol Chem; 2006 Sep; 281(36):26069-80. PubMed ID: 16835222
[TBL] [Abstract][Full Text] [Related]
34. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.
Lawler PR; Lawler J
Cold Spring Harb Perspect Med; 2012 May; 2(5):a006627. PubMed ID: 22553494
[TBL] [Abstract][Full Text] [Related]
35. Novel antiangiogenic pathway of thrombospondin-1 mediated by suppression of the cell cycle.
Yamauchi M; Imajoh-Ohmi S; Shibuya M
Cancer Sci; 2007 Sep; 98(9):1491-7. PubMed ID: 17596205
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Tie-2 signaling induces endothelial cell apoptosis, decreases Akt signaling, and induces endothelial cell expression of the endogenous anti-angiogenic molecule, thrombospondin-1.
Niu Q; Perruzzi C; Voskas D; Lawler J; Dumont DJ; Benjamin LE
Cancer Biol Ther; 2004 Apr; 3(4):402-5. PubMed ID: 14739779
[TBL] [Abstract][Full Text] [Related]
37. Ligand-induced growth and compaction of CD36 nanoclusters enriched in Fyn induces Fyn signaling.
Githaka JM; Vega AR; Baird MA; Davidson MW; Jaqaman K; Touret N
J Cell Sci; 2016 Nov; 129(22):4175-4189. PubMed ID: 27694211
[TBL] [Abstract][Full Text] [Related]
38. Expression, purification and structural characterization of functionally replete thrombospondin-1 type 1 repeats in a bacterial expression system.
Klenotic PA; Page RC; Misra S; Silverstein RL
Protein Expr Purif; 2011 Dec; 80(2):253-9. PubMed ID: 21821127
[TBL] [Abstract][Full Text] [Related]
39. Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain.
Margosio B; Rusnati M; Bonezzi K; Cordes BL; Annis DS; Urbinati C; Giavazzi R; Presta M; Ribatti D; Mosher DF; Taraboletti G
Int J Biochem Cell Biol; 2008; 40(4):700-9. PubMed ID: 17996481
[TBL] [Abstract][Full Text] [Related]
40. Blocking integrin inactivation as an anti-angiogenic therapy.
Saharinen P; Ivaska J
EMBO J; 2015 May; 34(10):1293-5. PubMed ID: 25828097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
